Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v1-EN
Language French English
Date Updated 2022-07-11 2022-02-04
Drug Identification Number 02507498 02507498
Brand name APO-SAXAGLIPTIN APO-SAXAGLIPTIN
Common or Proper name SAXAGLIPTIN SAXAGLIPTIN
Company Name APOTEX INC APOTEX INC
Ingredients SAXAGLIPTIN SAXAGLIPTIN
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 BLS 30 BLS
ATC code A10BH A10BH
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2022-02-03 2022-02-04
Estimated end date 2022-07-15 2022-05-20
Actual end date 2022-07-06
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments limited inventory has been allocated
Health Canada comments